CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,917 shares (to pay taxes)
- 4 Option exercise 10% owner acquired 500 shares (option exercise)
- 4 Option exercise 10% owner acquired 1,500 shares (option exercise)
- 4 Open-market sale 10% owner sold 213 shares at $19.75 ($4,207)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 165,150 shares at $15.77 ($2,604,416)
- 4 Open-market sale Director sold 630,374 shares at an average $16.14 ($10,174,788)
- 4 Open-market sale Director sold 737,989 shares at an average $16.10 ($11,883,340)
- 4 Open-market sale Director sold 620,133 shares at an average $16.50 ($10,233,811)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 849,257 shares at an average $17.10 ($14,518,963)
Page 1 of 11 · 212 filings